Affiliation:
1. Post Graduation in Pharmaceutical Sciences, State University of Paraíba, Campina Grande, Brazil
2. Therapeutic Innovation Postgraduate
Program, Federal University of Pernambuco, Recife, Brazil
Abstract
Abstract:
Topoisomerase inhibitors are extensively used in cancer chemotherapy. In the process of identifying novel anticancer compounds, biological evaluations are crucial and include, among others, the use of in silico and in vitro approaches. This work aimed to present recent research involving the obtainment and in silico and in vitro evaluation of topoisomerase I, II, and double inhibitors, of synthetic and natural origin, as potential compounds against tumor cells, in addition to proposing the construction of a desirable enzyme catalytic site. Therefore, it was observed that most Topoisomerase I inhibitors presented medium to large structures, with a rigid portion and a flexible region. In contrast, Topoisomerase IIα inhibitors showed medium and large structural characteristics, in addition to the planarity of the aromatic rings, which is mitigated due to flexible rings, but may also present elements that restrict conformation. The majority of compounds that exhibit dual inhibitory activity had relatively long chains, in addition to a flat and rigid portion suggestive of affinity for Topo I, and a flexible region characteristic of selective drugs for Topo II. Besides, it is noticed that most compounds that exhibit dual inhibitory showed similarities in the types of interactions and amino acids when compared to the selective compounds of Topo I and II. For instance, selective Topoisomerase I inhibitors interact with Arginine364 residues and selective Topoisomerase II inhibitors interact with Arginine487 residues, as both residues are targets for dual compounds.
Funder
FAPESQPB, Fundação de Apoio à Pesquisa do Estado da Paraíba
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Reference85 articles.
1. Almansour A.I.; Kumar R.S.; Arumugam N.; D-Ring-modified analogues of luotonin A with reduced planarity: Design, synthesis, and evaluation of their topoisomerase inhibition-associated cytotoxicity. BioMed Res Int 2019,2019,2514524
2. Park S.; Kadayat T.M.; Jun K.Y.; Novel 2-aryl-4-(4′-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors. Eur J Med Chem 2017,125,14-28
3. Azizi M.; Kokabi H.; Dianat-Moghadam H.; Mehrmohammadi M.; Introduction to cancer biology 2022,1-17
4. Hira I.; Kumari R.; Saini A.K.; Apoptotic cell death induction through pectin, guar gum and zinc oxide nanocomposite in A549 lung adenocarcinomas. Biointerface Res Appl Chem 2022,12,1856-1869
5. Wang S; Sun Z; Lei Z; Zhang HT; RNA-binding proteins and cancer metastasis. Semin Cancer Biol 2022,S1044-579X(22)00073-6
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献